DC
VTAE

Deere & Company’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Deere & Company’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-38,100
Closed -$411K – 1160
2016
Q2 		$411K Buy
+38,100
New +$326K 0.02% 740

Other funds holding VTAE

AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deere & Company's VTAE Position: Q3 2016 in Review

Deere & Company sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q3 2016, closing a stake of 38,100 shares — an estimated $411K sold.

Deere & Company first reported a position in VTAE in Q2 2016 and held it in 1 quarter. The position peaked at $411K in Q2 2016. 98 funds tracked by Wall St. Rank hold VTAE as of Q3 2016.

  • Deere & Company reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Deere & Company sold 38,100 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q3 2016, an estimated $411K.
  • Deere & Company first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • Deere & Company's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $411K in Q2 2016.
  • 98 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q3 2016.

Based on Deere & Company's 13F filing for Q3 2016, filed 14 Nov 2016.